Oorsprong van het eerstegraads netwerk van Amy Broidrick
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.
23
| Subsidiary | Pharmaceuticals: Major | 23 |
| Public Company | Pharmaceuticals: Major | 7 | |
| Subsidiary | Pharmaceuticals: Major | 5 | |
| Public Company | Pharmaceuticals: Other | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Amy Broidrick via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member | |
Qualigen, Inc.
 Qualigen, Inc. Medical SpecialtiesHealth Technology Qualigen, Inc. operates as a biotechnology company that develops and commercializes novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a diagnostic platform. The company was founded by Michael S. Poirier in 1996 and is headquartered in Carlsbad, CA. | Medical Specialties | Director/Board Member Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| KURA ONCOLOGY, INC. | Biotechnology | Founder | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| Walden University LLC | College/University | Doctorate Degree | |
| McGill University | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Doctorate Degree | |
| University of Toronto | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
Chamber of Commerce of The United States of America
 Chamber of Commerce of The United States of America Miscellaneous Commercial ServicesCommercial Services The Chamber of Commerce of The United States of America provides information on how businesses can adapt their workforce development and management strategies to deal with the changing labor market. The non-profit company is based in Washington and has subsidiaries in the United States. The Chamber of Commerce of The United States of America is the world's largest business organization, advocating, connecting, informing, and fighting for business growth and success. The American company was founded by Michael Scown, and Suzanne P. Clark has been the CEO of the company since 2014. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Barnard College | College/University | Undergraduate Degree | |
| New York Medical College | College/University | Doctorate Degree Doctorate Degree | |
| University College London | College/University | Undergraduate Degree | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Seville | College/University | Doctorate Degree | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree | |
| Merck Serono Co., Ltd. | President | ||
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | President | |
| Life Sciences Ontario | Director/Board Member | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| The Warren Alpert Medical School | College/University | Corporate Officer/Principal | |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Fight Against Cancer Innovation Trust
 Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust is a venture capital firm founded in 2014. The firm is headquartered in Toronto, Canada. | Investment Managers | Director/Board Member | |
| CARDIOL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Chairman | |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Pharmaceuticals: Other | Founder | |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Pharmaceuticals: Major | Founder | |
| European Pharmaceutical Market Research Association | Director/Board Member | ||
| Trinidad State Junior College | College/University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 36 |
| Canada | 9 |
| Duitsland | 2 |
| Verenigd Koninkrijk | 2 |
| Oostenrijk | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 15 |
| Finance | 4 |
| Commercial Services | 3 |
| Miscellaneous | 2 |
Operationeel
| Corporate Officer/Principal | 88 |
| Director/Board Member | 82 |
| Chief Tech/Sci/R&D Officer | 53 |
| Independent Dir/Board Member | 37 |
| Undergraduate Degree | 31 |
Sterkste connecties
| Insiders | |
|---|---|
| Charles Rowland | 25 |
| Stephen Webster | 23 |
| Paris Panayiotopoulos | 18 |
| Steven Schoenfeld | 15 |
| Allene Diaz | 14 |
| Deborah Brown | 13 |
| Sidney Emery | 13 |
| Joanne Quan | 12 |
| Joseph Leveque | 12 |
| Alise Reicin | 11 |
| James E. Hoyes | 10 |
| Jason G. Duncan | 9 |
| Bharat Tewarie | 9 |
| Ronald Shazer | 9 |
| Daguang Wang | 8 |
- Beurs
- Insiders
- Amy Broidrick
- Bedrijfsconnecties
